Type I interferons instigate fetal demise after Zika virus infection

Science Immunology

Volumn 3, Issue 19, 2018, Pages

  Yockey, Laura J ^a   Jurado, Kellie A ^a   Arora, Nitin ^b   Millet, Alon ^a   Rakib, Tasfia ^a   Milano, Kristin M ^a   Hastings, Andrew K ^a   Fikrig, Erol ^a,c   Kong, Yong ^d   Horvath, Tamas L ^a   Weatherbee, Scott ^a   Kliman, Harvey J ^a   Coyne, Carolyn B ^b,e   Iwasaki, Akiko ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d YALE UNIVERSITY   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; ALPHA BETA INTERFERON RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREEDING; CHORION VILLUS; CONTROLLED STUDY; CYTOSKELETON; DAM (ANIMAL); FEMALE; FETUS; GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IFNAR GENE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PLACENTA; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS REPLICATION; VIRUS TITRATION; ZIKA FEVER; ANIMAL; C57BL MOUSE; DISEASE MODEL; ETIOLOGY; FETUS DEATH; IMMUNOLOGY; INTRAUTERINE GROWTH RETARDATION; MOUSE; PREGNANCY; PREGNANCY COMPLICATION; UTERUS; VIROLOGY; ZIKA VIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FETAL DEATH; FETAL GROWTH RETARDATION; FETUS; HUMANS; INTERFERON TYPE I; MALE; MICE; MICE, INBRED C57BL; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECEPTOR, INTERFERON ALPHA-BETA; UTERUS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85046720968     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aao1680     Document Type: Article

References (61)

1. Pan American Health Organization/World Health Organization, Zika suspected and confirmed cases reported by countries and territories in the Americas Cumulative cases, 2015-2016 (Washington, D.C., 2016).
2. D. Baud, D. J. Gubler, B. Schaub, M. C. Lanteri, D. Musso, An update on Zika virus infection. Lancet 390, 2099–2109 (2017).
3. C. B. Coyne, H. M. Lazear, Zika virus—Reigniting the TORCH. Nat. Rev. Microbiol. 14, 707–715 (2016).
4. L. Barzon, M. Pacenti, E. Franchin, E. Lavezzo, M. Trevisan, D. Sgarabotto, G. Palù, Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016. Euro Surveill. 21, 30316 (2016).
5. E. D’Ortenzio, S. Matheron, Y. Yazdanpanah, X. de Lamballerie, B. Hubert, G. Piorkowski, M. Maquart, D. Descamps, F. Damond, I. Leparc-Goffart, Evidence of sexual transmission of Zika virus. N. Engl. J. Med. 2195–2198 (2016).
6. A. J. Sadler, B. R. G. Williams, Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559–568 (2008).
7. O. Takeuchi, S. Akira, Recognition of viruses by innate immunity. Immunol. Rev. 220, 214–224 (2007).
8. K. Honda, T. Taniguchi, IRFs: Master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6, 644–658 (2006).
9. J. W. Schoggins, C. M. Rice, Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1, 519–525 (2011).
10. J. Crouse, U. Kalinke, A. Oxenius, Regulation of antiviral T cell responses by type I interferons. Nat. Rev. Immunol. 15, 231–242 (2015).
11. M. Chawla-Sarkar, D. J. Lindner, Y.-F. Liu, B. R. Williams, G. C. Sen, R. H. Silverman, E. C. Borden, Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8, 237–249 (2003).
12. F. R. Cugola, I. R. Fernandes, F. B. Russo, B. C. Freitas, J. L. M. Dias, K. P. Guimarães, C. Benazzato, N. Almeida, G. C. Pignatari, S. Romero, C. M. Polonio, I. Cunha, C. L. Freitas, W. N. Brandão, C. Rossato, D. G. Andrade, D. de P. Faria, A. T. Garcez, C. A. Buchpigel, C. T. Braconi, E. Mendes, A. A. Sall, P. M. de A. Zanotto, J. P. S. Peron, A. R. Muotri, P. C. B. Beltrão, The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534, 267–271 (2016).
13. J. J. Miner, B. Cao, J. Govero, A. M. Smith, E. Fernandez, O. H. Cabrera, C. Garber, M. Noll, R. S. Klein, K. K. Noguchi, I. U. Mysorekar, M. S. Diamond, Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165, 1081–1091 (2016).
14. L. J. Yockey, L. Varela, T. Rakib, W. Khoury-Hanold, S. L. Fink, B. Stutz, K. Szigeti-Buck, A. Van den Pol, B. D. Lindenbach, T. L. Horvath, A. Iwasaki, Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection. Cell 166, 1247–1256.e4 (2016).
15. J. Xavier-Neto, M. Carvalho, B. dos Santos Pascoalino, A. C. Cardoso, Â. M. S. Costa, A. H. M. Pereira, L. N. Santos, Â. Saito, R. E. Marques, J. H. C. Smetana, S. R. Consonni, C. Bandeira, V. V. Costa, M. C. Bajgelman, P. S. Lopes de Oliveira, M. T. Cordeiro, L. H. V. G. Gil, B. A. Pauletti, D. C. Granato, A. F. P. Leme, L. Freitas-Junior, C. B. M. Holanda de Freitas, M. M. Teixeira, E. Bevilacqua, K. Franchini, Hydrocephalus and arthrogryposis in an immunocompetent mouse model of ZIKA teratogeny: A developmental study. PLOS Neglected Trop. Dis. 11, e0005363 (2017).
16. C. W. Winkler, T. A. Woods, R. Rosenke, D. P. Scott, S. M. Best, K. E. Peterson, Sexual and vertical transmission of Zika virus in anti-interferon receptor-treated Rag-1deficient mice. Sci. Rep. 7, 7176 (2017).
17. A. Grant, S. S. Ponia, S. Tripathi, V. Balasubramaniam, L. Miorin, M. Sourisseau, M. C. Schwarz, M. P. Sánchez-Seco, M. J. Evans, S. M. Best, A. García-Sastre, Zika virus targets human STAT2 to inhibit type I interferon signaling. Cell Host Microbe 19, 882–890 (2016).
18. Y. Wu, Q. Liu, J. Zhou, W. Xie, C. Chen, Z. Wang, H. Yang, J. Cui, Zika virus evades interferon-mediated antiviral response through the co-operation of multiple nonstructural proteins in vitro. Cell Discov. 3, 17006 (2017).
19. H. M. Lazear, J. Govero, A. M. Smith, D. J. Platt, E. Fernandez, J. J. Miner, M. S. Diamond, A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720–730 (2016).
20. B. W. Jagger, J. J. Miner, B. Cao, N. Arora, A. M. Smith, A. Kovacs, I. U. Mysorekar, C. B. Coyne, M. S. Diamond, Gestational stage and IFN- signaling regulate ZIKV infection in utero. Cell Host Microbe 22, 366–376.e3 (2017).
21. J. R. Robbins, A. I. Bakardjiev, Pathogens and the placental fortress. Curr. Opin. Microbiol. 15, 36–43 (2012).
22. T. Cotechini, C. H. Graham, Aberrant maternal inflammation as a cause of pregnancy complications: A potential therapeutic target? Placenta 36, 960–966 (2015).
23. M. Prabhudas, E. Bonney, K. Caron, S. Dey, A. Erlebacher, A. Fazleabas, S. Fisher, T. Golos, M. Matzuk, J. M McCune, G. Mor, L. Schulz, M. Soares, T. Spencer, J. Strominger, S. S. Way, K. Yoshinaga, Immune mechanisms at the maternal-fetal interface: Perspectives and challenges. Nat. Immunol. 16, 328–334 (2015).
24. G. Mor, Placental inflammatory response to Zika virus may affect fetal brain development. Am. J. Reprod. Immunol. 75, 421–422 (2016).
25. M. Cappelletti, P. Presicce, M. J. Lawson, V. Chaturvedi, T. E. Stankiewicz, S. Vanoni, I. T. W. Harley, J. W. McAlees, D. A. Giles, M. E. Moreno-Fernandez, C. M. Rueda, P. Senthamaraikannan, X. Sun, R. Karns, K. Hoebe, E. M. Janssen, C. L. Karp, D. A. Hildeman, S. P. Hogan, S. G. Kallapur, C. A. Chougnet, S. S. Way, S. Divanovic, Type I interferons regulate susceptibility to inflammation-induced preterm birth. JCI Insight 2, e91288 (2017).
26. K. Racicot, P. Aldo, A. El-guindy, J.-Y. Kwon, R. Romero, G. Mor, Cutting edge: Fetal/ placental type I IFN can affect maternal survival and fetal viral load during viral infection. J. Immunol. 198, 3029–3032 (2017).
27. R. M. Roberts, Interferon-tau, a type 1 interferon involved in maternal recognition of pregnancy. Cytokine Growth Factor Rev. 18, 403–408 (2007).
28. A. Bayer, N. J. Lennemann, Y. Ouyang, J. C. Bramley, S. Morosky, E. Torres De Azeved Marques Jr., S. Cherry, Y. Sadovsky, C. B. Coyne, Type III interferons produced by human placental trophoblasts confer protection against Zika virus infection. Cell Host Microbe 19, 705–712 (2016).
29. J. Corry, N. Arora, C. A. Good, Y. Sadovsky, C. B. Coyne, Organotypic models of type III interferon-mediated protection from Zika virus infections at the maternal–fetal interface. Proc. Natl. Acad. Sci. U.S.A. 114, 9433–9438 (2017).
30. J. L. Sones, R. L. Davisson, Preeclampsia, of mice and women. Physiol. Genomics 48, 565–572 (2016).
31. V. E. Papaioannou, R. R. Behringer, Early embryonic lethality in genetically engineered mice: Diagnosis and phenotypic analysis. Vet. Pathol. 49, 64–70 (2012).
32. P. M. Coan, A. C. Ferguson-Smith, G. J. Burton, Ultrastructural changes in the interhaemal membrane and junctional zone of the murine chorioallantoic placenta across gestation. J. Anat. 207, 783–796 (2005).
33. J. Rossant, J. C. Cross, Placental development: Lessons from mouse mutants. Nat. Rev. Genet. 2, 538–548 (2001).
34. M. Mori, A. Bogdan, T. Balassa, T. Csabai, J. Szekeres-Bartho, The decidua—the maternal bed embracing the embryo—maintains the pregnancy. Semin. Immunopathol. 38, 635–649 (2016).
35. J. Bhatnagar, D. B. Rabeneck, R. B. Martines, S. Reagan-Steiner, Y. Ermias, L. B. C. Estetter, T. Suzuki, J. M. Ritter, M. K. Keating, G. Hale, J. Gary, A. Muehlenbachs, A. J. Lambert, R. Lanciotti, T. Oduyebo, D. Meaney-Delman, F. Bolaños, E. A. Parra Saad, W.-J. Shieh, S. R. Zaki, Zika virus RNA replication and persistence in brain and placenta tissue. Emerg. Infect. Dis. 23, 405–414 (2017).
36. A. Dupressoir, C. Vernochet, O. Bawa, F. Harper, G. Pierron, P. Opolon, T. Heidmann, Syncytin-A knockout mice demonstrate the critical role in placentation of a fusogenic, endogenous retrovirus-derived, envelope gene. Proc. Natl. Acad. Sci. U.S.A. 106, 12127–12132 (2009).
37. M. Ream, A. M. Ray, R. Chandra, D. M. Chikaraishi, Early fetal hypoxia leads to growth restriction and myocardial thinning. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R583–R595 (2008).
38. R. Trollmann, H. Rehrauer, C. Schneider, G. Krischke, N. Huemmler, S. Keller, W. Rascher, M. Gassmann, Late-gestational systemic hypoxia leads to a similar early gene response in mouse placenta and developing brain. Am. J. Physiol. 299, R1489–R1499 (2010).
39. M. Matsumoto, T. Seya, TLR3: Interferon induction by double-stranded RNA including poly(I:C). Adv. Drug Deliv. Rev. 60, 805–812 (2008).
40. −/− mice. J. Immunol. 190, 3639–3647 (2013).
41. G. J. Burton, C. J. P. Jones, Syncytial knots, sprouts, apoptosis, and trophoblast deportation from the human placenta. Taiwan. J. Obstet. Gynecol. 48, 28–37 (2009).
42. N. M. E. Fogarty, A. C. Ferguson-Smith, G. J. Burton, Syncytial knots (Tenney-Parker changes) in the human placenta: Evidence of loss of transcriptional activity and oxidative damage. Am. J. Pathol. 183, 144–152 (2013).
43. R. Uraki, K. A. Jurado, J. Hwang, K. Szigeti-Buck, T. L. Hovarth, A. Iwasaki, E. Fikrig, Fetal growth restriction caused by sexual transmission of Zika virus in mice. J. Infect. Dis. 215, 1720–1724 (2017).
44. K. Loukeris, R. Sela, R. N. Baergen, Syncytial knots as a reflection of placental maturity: Reference values for 20 to 40 weeks’ gestational age. Pediatr. Dev. Pathol. 13, 305–309 (2010).
45. C. Odendall, J. C. Kagan, The unique regulation and functions of type III interferons in antiviral immunity. Curr. Opin. Virol. 12, 47–52 (2015).
46. R. A. B. Ezekowitc, J. B. Mulliken, J. Folkman, Interferon Alfa-2a therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med. 326, 1456–1463 (1992).
47. G. Mameli, A. Dolei, V. Astone, K. Khalili, C. Serra, B. E. Sawaya, Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines. Virology 362, 120–130 (2007).
48. G. Teklenburg, M. Salker, M. Molokhia, S. Lavery, G. Trew, T. Aojanepong, H. J. Mardon, A. U. Lokugamage, R. Rai, C. Landles, B. A. J. Roelen, S. Quenby, E. W. Kuijk, A. Kavelaars, C. J. Heijnen, L. Regan, J. J. Brosens, N. S. Macklon, Natural selection of human embryos: Decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation. PLOS ONE 5, e10258 (2010).
49. E. C. Larsen, O. B. Christiansen, A. M. Kolte, N. Macklon, New insights into mechanisms behind miscarriage. BMC Med. 11, 154 (2013).
50. Y. J. Crow, Type I interferonopathies: A novel set of inborn errors of immunity. Ann. N.Y. Acad. Sci. 1238, 91–98 (2011).
51. D. Andrade, M. Kim, L. P. Blanco, S. A. Karumanchi, G. C. Koo, P. Redecha, K. Kirou, A. M. Alvarez, M. J. Mulla, M. K. Crow, V. M. Abrahams, M. J. Kaplan, J. E. Salmon, Interferon- and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis Rheumatol. 67, 977–987 (2015).
52. M. Onorati, Z. Li, F. Liu, A. M. M. Sousa, N. Nakagawa, M. Li, M. T. Dell’Anno, F. O. Gulden, S. Pochareddy, A. T. N. Tebbenkamp, W. Han, M. Pletikos, T. Gao, Y. Zhu, C. Bichsel, L. Varela, K. Szigeti-Buck, S. Lisgo, Y. Zhang, A. Testen, X.-B. Gao, J. Mlakar, M. Popovic, M. Flamand, S. M. Strittmatter, L. K. Kaczmarek, E. S. Anton, T. L. Horvath, B. D. Lindenbach, N. Sestan, Zika virus disrupts phospho-TBK1 localization and mitosis in human neuroepithelial stem cells and radial glia. Cell Rep. 16, 2576–2592 (2016).
53. A. N. van den Pol, G. Mao, Y. Yang, S. Ornaghi, J. N. Davis, Zika virus targeting in the developing brain. J. Neurosci. 37, 2161–2175 (2017).
54. C. A. Mcconkey, E. Delorme-Axford, C. A. Nickerson, K. S. Kim, Y. Sadovsky, J. P. Boyle, C. B. Coyne, A three-dimensional culture system recapitulates placental syncytiotrophoblast development and microbial resistance. Sci. Adv. 2, e1501462 (2016).
55. M. I. Love, W. Huber, S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
56. Y. Kong, Btrim: A fast, lightweight adapter and quality trimming program for next-generation sequencing technologies. Genomics 98, 152–153 (2011).
57. D. Kim, G. Pertea, C. Trapnell, H. Pimentel, R. Kelley, S. L. Salzberg, TopHat2: Accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
58. A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, J. P. Mesirov, Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545–15550 (2005).
59. V. K. Mootha, C. M. Lindgren, K.-F. Eriksson, A. Subramanian, S. Sihag, J. Lehar, P. Puigserver, E. Carlsson, M. Ridderstråle, E. Laurila, N. Houstis, M. J. Daly, N. Patterson, J. P. Mesirov, T. R. Golub, P. Tamayo, B. Spiegelman, E. S. Lander, J. N. Hirschhorn, D. Altshuler, L. C. Groop, PGC-1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003).
60. E. F. Foxman, J. A. Storer, M. E. Fitzgerald, B. R. Wasike, L. Houf, H. Zhaof, P. E. Turnere, A. Marie Pyle, A. Iwasaki, Temperature-dependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells. Proc. Natl. Acad. Sci. U.S.A. 112, 827–832 (2014).
61. V. C. Thompson, T. K. Day, T. Bianco-Miotto, L. A. Selth, G. Han, M. Thomas, G. Buchanan, H. I. Scher, C. C. Nelson; Australian Prostate Cancer BioResource, N. M. Greenberg, L. M. Butler, W. D. Tilley, A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease. Int. J. Cancer 131, 662–672 (2012).